1. Home
  2. MLEC vs BBLG Comparison

MLEC vs BBLG Comparison

Compare MLEC & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$0.27

Market Cap

2.6M

Sector

Finance

ML Signal

HOLD

BBLG

Bone Biologics Corp

HOLD

Current Price

$1.51

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
BBLG
Founded
2008
2004
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLEC
BBLG
Price
$0.27
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
382.7K
870.8K
Earning Date
01-30-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
170.36
N/A
52 Week Low
$0.21
$1.30
52 Week High
$8.00
$7.74

Technical Indicators

Market Signals
Indicator
MLEC
BBLG
Relative Strength Index (RSI) 31.56 33.35
Support Level $0.21 $1.76
Resistance Level $0.32 $2.39
Average True Range (ATR) 0.05 0.18
MACD -0.00 -0.05
Stochastic Oscillator 15.74 4.09

Price Performance

Historical Comparison
MLEC
BBLG

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Share on Social Networks: